Equity Capital Markets
Allogene Therapeutics, Inc.
04/26
Âé¶¹´«Ã½ served as bookrunner for Allogene Therapeutics, Inc. on its follow-on offering
Sub-Type
Follow-On Offering
Sector
Sub-Sector
Biopharma